Market Closed -
Other stock markets
|
After market 12:17:18 pm | |||
96.18 EUR | +0.55% | 96.18 | 0.00% |
May. 06 | Syensqo: CEO appointed to head chemical federation | CF |
Apr. 29 | Syensqo: completes acquisition of South Korean JinYoung Bio | CF |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company is highly valued given the cash flows generated by its activity.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.04% | 10.89B | - | ||
-0.96% | 74.01B | B | ||
+1.76% | 47.66B | A- | ||
+1.83% | 32.76B | C | ||
+10.03% | 18.17B | B | ||
+12.07% | 11.85B | A- | ||
-14.66% | 11.16B | B | ||
+0.72% | 9.49B | A- | ||
-2.13% | 8.35B | B | ||
-7.78% | 8.11B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SYENS Stock
- Ratings Syensqo SA/NV